Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 60.69 Thousand USD | -89.85% |
| 2022 | 598.08 Thousand USD | -63.45% |
| 2021 | 1.63 Million USD | 464.93% |
| 2020 | 289.65 Thousand USD | 432.82% |
| 2019 | 54.36 Thousand USD | -92.2% |
| 2018 | 697.05 Thousand CAD | -64.47% |
| 2017 | 1.96 Million CAD | 42.64% |
| 2016 | 1.37 Million CAD | 118.73% |
| 2015 | 628.84 Thousand CAD | 178.67% |
| 2014 | 225.66 Thousand CAD | -13.37% |
| 2013 | 260.48 Thousand CAD | 19.68% |
| 2012 | 217.64 Thousand CAD | -5.26% |
| 2011 | 229.73 Thousand CAD | 990.68% |
| 2010 | 21.06 Thousand CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 20.46 Thousand CAD | 208.28% |
| 2024 Q1 | 6639.37 USD | -67.63% |
| 2023 Q4 | 20.5 Thousand USD | 17.19% |
| 2023 Q3 | 17.5 Thousand USD | -5.82% |
| 2023 Q1 | 3589.79 USD | -98.86% |
| 2023 FY | 60.69 Thousand USD | -89.85% |
| 2023 Q2 | 18.58 Thousand USD | 417.66% |
| 2022 Q2 | 83.85 Thousand CAD | -54.08% |
| 2022 Q1 | 182.61 Thousand CAD | -72.83% |
| 2022 FY | 598.08 Thousand USD | -63.45% |
| 2022 Q4 | 313.61 Thousand USD | 781.43% |
| 2022 Q3 | 35.58 Thousand USD | -57.57% |
| 2021 Q2 | 977.74 Thousand CAD | 292.53% |
| 2021 FY | 1.63 Million USD | 464.93% |
| 2021 Q1 | 249.08 Thousand CAD | -2.31% |
| 2021 Q4 | 672.04 Thousand CAD | 102.94% |
| 2021 Q3 | 331.15 Thousand CAD | -66.13% |
| 2020 Q4 | 254.98 Thousand CAD | 154.87% |
| 2020 Q3 | 100.04 Thousand CAD | 331.74% |
| 2020 Q1 | 19.19 Thousand CAD | -54.51% |
| 2020 FY | 289.65 Thousand USD | 432.82% |
| 2020 Q2 | 23.17 Thousand CAD | 20.74% |
| 2019 Q1 | 18.45 Thousand CAD | 101.48% |
| 2019 FY | 54.36 Thousand USD | -92.2% |
| 2019 Q4 | 42.18 Thousand CAD | 298.8% |
| 2019 Q3 | 10.57 Thousand CAD | -34.01% |
| 2019 Q2 | 16.03 Thousand CAD | -13.14% |
| 2018 FY | 697.05 Thousand CAD | -64.47% |
| 2018 Q4 | -1.24 Million CAD | -376.81% |
| 2018 Q3 | 449.09 Thousand CAD | -37.11% |
| 2018 Q2 | 714.13 Thousand CAD | -30.93% |
| 2018 Q1 | 1.03 Million CAD | 22.82% |
| 2017 Q1 | 457.42 Thousand CAD | 35.94% |
| 2017 Q3 | 521.17 Thousand CAD | -28.91% |
| 2017 FY | 1.96 Million CAD | 42.64% |
| 2017 Q2 | 733.16 Thousand CAD | 60.28% |
| 2017 Q4 | 841.85 Thousand CAD | 61.53% |
| 2016 Q4 | 336.49 Thousand CAD | -23.37% |
| 2016 Q2 | 589.47 Thousand CAD | 1.2% |
| 2016 Q1 | 582.47 Thousand CAD | 299.27% |
| 2016 FY | 1.37 Million CAD | 118.73% |
| 2016 Q3 | 439.12 Thousand CAD | -25.5% |
| 2015 Q2 | 263.5 Thousand CAD | 63.43% |
| 2015 Q4 | 145.88 Thousand CAD | -46.48% |
| 2015 Q3 | 272.58 Thousand CAD | 3.45% |
| 2015 FY | 628.84 Thousand CAD | 178.67% |
| 2015 Q1 | 161.22 Thousand CAD | 100.24% |
| 2014 Q3 | 103.02 Thousand CAD | 118.25% |
| 2014 Q2 | 47.2 Thousand CAD | 46.98% |
| 2014 Q1 | 32.11 Thousand CAD | -60.51% |
| 2014 FY | 225.66 Thousand CAD | -13.37% |
| 2014 Q4 | 80.51 Thousand CAD | -21.85% |
| 2013 Q3 | 40.64 Thousand CAD | -68.01% |
| 2013 FY | 260.48 Thousand CAD | 19.68% |
| 2013 Q1 | 25.12 Thousand CAD | -20.93% |
| 2013 Q2 | 127.04 Thousand CAD | 405.74% |
| 2013 Q4 | 81.32 Thousand CAD | 100.1% |
| 2012 Q4 | 31.77 Thousand CAD | -17.67% |
| 2012 Q1 | 73.4 Thousand CAD | -16.37% |
| 2012 Q2 | 74.04 Thousand CAD | 0.86% |
| 2012 Q3 | 38.59 Thousand CAD | -47.88% |
| 2012 FY | 217.64 Thousand CAD | -5.26% |
| 2011 Q4 | 87.77 Thousand CAD | 44.09% |
| 2011 FY | 229.73 Thousand CAD | 990.68% |
| 2011 Q1 | 35.35 Thousand CAD | 162.55% |
| 2011 Q3 | 60.91 Thousand CAD | 33.34% |
| 2011 Q2 | 45.68 Thousand CAD | 29.23% |
| 2010 FY | 21.06 Thousand CAD | 0.0% |
| 2010 Q2 | 7.00 CAD | 0.0% |
| 2010 Q3 | 7571.00 CAD | 108057.14% |
| 2010 Q4 | 13.46 Thousand CAD | 77.85% |
| 2009 FY | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | 91.805% |
| IR-Med Inc. | 4.89 Million USD | 98.76% |
| Polarean Imaging plc | 12.24 Million USD | 99.504% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 95.403% |
| Avitar, Inc. | 3.56 Million USD | 98.3% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.925% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 91.366% |
| Össur hf. | 396.18 Million USD | 99.985% |
| Zecotek Photonics Inc. | 3.46 Million USD | 98.246% |
| QHSLab, Inc. | 961.65 Thousand USD | 93.688% |
| Wellstar International, Inc. | 1.79 Million USD | 96.618% |
| Össur hf. | 396.18 Million USD | 99.985% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 99.721% |
| Escalon Medical Corp. | 5.25 Million USD | 98.844% |
| Aurora Spine Corporation | 8.65 Million USD | 99.299% |
| BrainsWay Ltd. | 28.01 Million USD | 99.783% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 99.365% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 99.819% |
| Vivos Inc. | 2.78 Million USD | 97.822% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.994% |
| Kelyniam Global, Inc. | 2.27 Million USD | 97.332% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 94.019% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 86.062% |
| Nanomix Corporation | 8.36 Million USD | 99.275% |
| Theraclion SA | 7.43 Million USD | 99.184% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 95.311% |
| Positron Corporation | 1 Million USD | 93.974% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 98.049% |
| Lombard Medical, Inc. | 30.29 Million USD | 99.8% |
| ALR Technologies Inc. | 6.33 Million USD | 99.042% |
| Stratec SE | 46.32 Million USD | 99.869% |
| Vycor Medical, Inc. | 1.27 Million USD | 95.241% |
| Heart Tronics, Inc. | 14.46 Million USD | 99.58% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | 49.639% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 70.595% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 99.571% |
| VMS Rehab Systems, Inc. | 63.63 USD | -95292.111% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 98.262% |
| Ingen Technologies, Inc. | 1.88 Million USD | 96.775% |
| Odyssey Group International, Inc. | -14.26 Million USD | 100.426% |
| United American Healthcare Corporation | 59 Thousand USD | -2.878% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 85.104% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 90.437% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 96.42% |
| Urologix, Inc. | 10.09 Million USD | 99.399% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 95.195% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 98.98% |
| SS Innovations International, Inc. | 21.38 Million USD | 99.716% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 73.637% |
| Smith & Nephew plc | 3.46 Billion USD | 99.998% |
| NIOX Group Plc | 22.27 Million USD | 99.728% |
| Fuse Medical, Inc. | 10.35 Million USD | 99.414% |
| Broncus Holding Corporation | 38.15 Million USD | 99.841% |
| Brain Scientific Inc. | 9.66 Million USD | 99.372% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 99.411% |